2025
SJR Q1
JCR Q2 · 3,3
OA
168 matched articles
SCIE
Journal detail
Journal of Cancer Research and Clinical Oncology
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
0171521614321335
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,954
- Quartile Q1
- H-Index 118
- Cites/doc 3,4
- Docs (3y) 2.229
- Cites (3y) 7.623
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,3
- 5Y JIF 3,3
- JCI 0,63
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Medicine (miscellaneous) Q1
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,954 | 3,3 | 3,3 | 0,63 | Q2 | 118 |
| 2024 | Q1 | Q2 | 0,91 | 2,8 | 3,1 | 0,61 | Q3 | 114 |
| 2023 | Q1 | Q3 | 1,023 | 2,7 | 3,1 | 0,62 | Q3 | 114 |
| 2022 | Q1 | Q2 | 1,017 | 3,6 | 3,8 | 0,71 | Q2 | 114 |
| 2021 | Q1 | Q2 | 1,058 | 4,3 | 4,2 | 0,79 | Q2 | 114 |
| 2020 | Q1 | Q2 | 1,338 | 4,6 | 4,2 | 0,9 | Q2 | 114 |
| 2019 | Q1 | Q2 | 1,111 | 3,7 | 3,3 | 0,86 | Q2 | 114 |
| 2018 | — | Q2 | — | 3,3 | 3 | 0,86 | Q2 | — |
| 2017 | Q1 | Q2 | 1,235 | 3,3 | 3,1 | 0,82 | Q2 | 114 |
| 2016 | Q1 | Q2 | 1,296 | 3,5 | 3,1 | — | — | 114 |
| 2015 | Q1 | Q2 | 1,222 | 3,1 | 3 | — | — | 114 |
| 2014 | Q1 | Q2 | 1,306 | 3,1 | 2,9 | — | — | 114 |
| 2013 | Q1 | Q2 | 1,318 | 3 | 2,8 | — | — | 114 |
| 2012 | Q1 | Q2 | 1,185 | 2,9 | 2,7 | — | — | 114 |
| 2011 | Q1 | Q2 | 1,166 | 2,6 | 2,5 | — | — | 114 |
| 2010 | Q1 | Q2 | 1,142 | 2,5 | 2,4 | — | — | 114 |
| 2009 | — | Q3 | — | 2,3 | 2,4 | — | — | — |
| 2008 | — | Q3 | — | 2,2 | 2,6 | — | — | — |
| 2007 | — | Q3 | — | 2,4 | 2,5 | — | — | — |
| 2006 | — | Q2 | — | 2,5 | — | — | — | — |
| 2005 | — | Q2 | — | 2,5 | — | — | — | — |
| 2004 | — | Q2 | — | 2,4 | — | — | — | — |
| 2003 | — | Q3 | — | 2,2 | — | — | — | — |
| 2002 | — | Q2 | — | 2,2 | — | — | — | — |
| 2001 | — | Q2 | — | 2,2 | — | — | — | — |
| 2000 | — | Q2 | — | 1,8 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q3 | — | 1,2 | — | — | — | — |
| 1997 | — | Q3 | — | 1,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 158/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q3 | 160/328 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 163/322 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 118/241 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 119/245 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 103/242 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q2 | 102/244 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 99/230 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 108/223 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 85/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 94/213 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 90/211 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 81/203 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 84/197 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 97/196 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 92/185 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 89/166 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 93/143 |
| 2007 | ONCOLOGY | SCIE | Q3 | — | 73/132 |
| 2006 | ONCOLOGY | SCIE | Q2 | — | 61/127 |
| 2005 | ONCOLOGY | SCIE | Q2 | — | 58/123 |
| 2004 | ONCOLOGY | SCIE | Q2 | — | 57/123 |
| 2003 | ONCOLOGY | SCIE | Q3 | — | 61/120 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 49/114 |
| 2001 | ONCOLOGY | SCIE | Q2 | — | 46/107 |
| 2000 | ONCOLOGY | SCIE | Q2 | — | 48/103 |
| 1999 | ONCOLOGY | SCIE | Q3 | — | 71/105 |
| 1998 | ONCOLOGY | SCIE | Q3 | — | 59/104 |
| 1997 | ONCOLOGY | SCIE | Q3 | — | 53/102 |